Drug intelligence / Profile preview

colony stimulating factor 1

Development stage
Unknown
Lead developer
绿十字
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous
01

Overview

Colony stimulating factor 1 (CSF1), also known as macrophage colony-stimulating factor (M-CSF), is a cytokine and hematopoietic growth factor that plays an essential role in the regulation of survival, proliferation, and differentiation of hematopoietic precursor cells, particularly mononuclear phagocytes such as macrophages and monocytes. It binds to the colony stimulating factor 1 receptor (CSF1R) to activate downstream signaling pathways. Recombinant and purified forms of CSF1, including lanimostim, mirimostim, and cilmostim, have been developed for clinical use. Mirimostim (marketed as Leukoprol) is approved in Japan for the treatment of neutropenia and to facilitate hematopoietic recovery after bone marrow transplantation or intensive chemotherapy. Other forms have been investigated for indications such as hypercholesterolemia and infectious diseases.

Brand names
CostilateLeukoprol
Other names
CSF-1CSF1CSF 1M-CSFMCSFcilmostimlanimostimmacrophage colony-stimulating factormacrophage colony-stimulating factor 1mirimostimrecombinant colony-stimulating factor 1recombinant human M-CSFrecombinant human colony stimulating factor 1rhCSF-1rhCSF1rhCSF 1rhM-CSFrM-CSF
02

Targets

CSF1R (Macrophage colony-stimulating factor receptor)

Beyond the preview

Go deeper on colony stimulating factor 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on colony stimulating factor 1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call